Komori
Susmed (4263) · InitiativeFirst stated

サスメド: Launch of Sales and Wider Adoption of Medcle®, an App for Insomnia Disorder

First written in FY2026. . Latest entry: FY2026.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Expansion of sales and adoption of SUSMED’s Medcle app for insomnia disorderA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2026First statedAnnual report

    「Sales of the “サスメド insomnia disorder app Medcle®” began in June 2026, and the company is working to expand the number of adopting medical institutions and improve awareness among medical institutions and patients.」

    Following the start of sales after reimbursement listing approval, the company identified expansion of adopting medical institutions, increased awareness among medical institutions and patients, and promotional activities such as conference exhibitions and webinars as new business operating themes.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Susmed yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
サスメド: Launch of Sales and Wider Adoption of Medcle®, an App for Insomnia Disorder | SUSMED,Inc. (4263) | Komori